Developing a new test to improve sepsis outcomes
NHS using Imperial spinout’s advanced prescription software to improve safety
Work starts on world’s most sensitive ultra-rare particle detector
Imperial ECMC's main objectives are to develop novel imaging, biomarker and therapeutic approaches that will aid cancer diagnosis and treatment.
Top links